Direct and indirect co-culture of chondrocytes and mesenchymal stem cells for the generation of polymer/extracellular matrix hybrid constructs
Source abstract
Abstract
In this work, the influence of direct cell-cell contact in co-cultures of mesenchymal stem cells (MSCs) and chondrocytes for the improved deposition of cartilage-like extracellular matrix (ECM) within nonwoven fibrous poly(∊-caprolactone) (PCL) scaffolds was examined. To this end, chondrocytes and MSCs were either co-cultured in direct contact by mixing on a single PCL scaffold or produced via indirect co-culture, whereby the two cell types were seeded on separate scaffolds which were then cultured together in the same system either statically or under media perfusion in a bioreactor. In static cultures, the chondrocyte scaffold of an indirectly co-cultured group generated significantly greater amounts of glycosaminoglycan and collagen than the direct co-culture group initially seeded with the same number of chondrocytes. Furthermore, improved ECM production was linked to greater cellular proliferation and distribution throughout the scaffold in static culture. In perfusion cultures, flow had a significant effect on the proliferation of the chondrocytes. The ECM contents within the chondrocyte-containing scaffolds of the indirect co-culture groups either approximated or surpassed the amounts generated within the direct co-culture group. Additionally, within bioreactor culture there were indications that chondrocytes had an influence on the chondrogenesis of MSCs as evidenced by increases in cartilaginous ECM synthetic capacity. This work demonstrates that it is possible to generate PCL/ECM hybrid scaffolds for cartilage regeneration by utilizing the factors secreted by two different cell types, chondrocytes and MSCs, even in the absence of juxtacrine signaling.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Electrospun Nanofibers in Biomedical Applications · Periodontal Regeneration and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (58)
Show source-provided references
1. Growth factor-loaded scaffolds for bone engineering10.1016/j.jconrel.2004.07.005 ↗
2. Delivery of TGF-[beta]1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications10.1016/j.biomaterials.2005.05.083 ↗
3. Oxygen producing biomaterials for tissue regeneration10.1016/j.biomaterials.2007.07.003 ↗
4. Substrates for cardiovascular tissue engineering10.1016/j.addr.2011.01.007 ↗
5. Treatment of osteochondral defects with autologous bone marrow in a hyaluronan-based delivery vehicle10.1089/107632702753725085 ↗
6. Proliferation, regeneration, and repair of articular cartilage of immature animals10.2106/00004623-196244030-00001 ↗
7. Role of growth factors in rabbit articular cartilage repair by chondrocytes in agarose10.1053/joca.2001.0444 ↗
8. Extracellular matrix scaffolds for cartilage and bone regeneration10.1016/j.tibtech.2012.12.004 ↗
9. Electrospinning of collagen type II: a feasibility study10.1177/0883911503018002003 ↗
10. Articular cartilage: structure, injuries and review of management10.1093/bmb/ldn025 ↗
11. Evaluating osteochondral defect repair potential of autologous rabbit bone marrow cells on type II collagen scaffold10.1007/s10616-010-9314-9 ↗
12. Mimicked bioartificial matrix containing chondroitin sulphate on a textile scaffold of poly(3-hydroxybutyrate) alters the differentiation of adult human mesenchymal stem cells10.1089/ten.2006.12.345 ↗
13. Evaluation of the growth of chondrocytes and osteoblasts seeded into precision scaffolds fabricated by fused deposition manufacturing10.1002/jbm.b.30626 ↗
14. Bioactive polymer/extracellular matrix scaffolds fabricated with a flow perfusion bioreactor for cartilage tissue engineering10.1016/j.biomaterials.2010.07.110 ↗
15. Levorson EJ, Mountziaris PM, Hu O, Kasper FK, Mikos AG. Cell derived polymer/extracellular matrix composite scaffolds for cartilage regeneration. Part 1. Investigation of co-cultures and seeding densities for improved extracellular matrix deposition. Tissue Eng Part C Methods 2013. http://dx.doi.org/10.1089/ten.TEC.2013.0286 [Epub ahead of print].10.1089/ten.tec.2013.0286 ↗
16. Enhanced chondrogenesis in co-cultures with articular chondrocytes and mesenchymal stem cells10.1016/j.biomaterials.2012.05.042 ↗
17. In vitro stage-specific chondrogenesis of mesenchymal stem cells committed to chondrocytes10.1002/art.24265 ↗
18. Co-culture in cartilage tissue engineering10.1002/term.19 ↗
19. Morphogenetic signals from chondrocytes promote chondrogenic and osteogenic differentiation of mesenchymal stem cells10.1002/jcp.21052 ↗
20. Human articular chondrocytes secrete parathyroid hormone–related protein and inhibit hypertrophy of mesenchymal stem cells in coculture during chondrogenesis10.1002/art.27565 ↗
21. Coculture of human mesenchymal stem cells and articular chondrocytes reduces hypertrophy and enhances functional properties of engineered cartilage10.1089/ten.tea.2010.0531 ↗
22. Trophic effects of mesenchymal stem cells increase chondrocyte proliferation and matrix formation10.1089/ten.tea.2010.0517 ↗
23. Mesenchymal stem cells secrete factors that inhibit inflammatory processes in short-term osteoarthritic synovium and cartilage explant culture10.1016/j.joca.2012.06.003 ↗
24. Trophic effects of mesenchymal stem cells in chondrocyte co-cultures are independent of culture conditions and cell sources10.1089/ten.tea.2011.0715 ↗
25. In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis10.1073/pnas.052716199 ↗
26. Coculture of equine mesenchymal stem cells and mature equine articular chondrocytes results in improved chondrogenic differentiation of the stem cells
27. Soluble signalling factors derived from differentiated cartilage tissue affect chondrogenic differentiation of rat adult marrow stromal cells10.1159/000107728 ↗
28. Levorson EJ, Hu O, Mountziaris PM, Kasper FK, Mikos AG. Cell derived polymer/extracellular matrix composite scaffolds for cartilage regeneration. Part 2. Construct Devitalization and Determination of Chondroinductive Capacity. Tissue Eng Part C Methods 2013. http://dx.doi.org/10.1089/ten.tec.2013.0288 [Epub ahead of print].10.1089/ten.tec.2013.0288 ↗
29. Fabrication and characterization of multiscale electrospun scaffolds for cartilage regeneration10.1088/1748-6041/8/1/014103 ↗
30. The effect of hypoxia on the chondrogenic differentiation of co-cultured articular chondrocytes and mesenchymal stem cells in scaffolds10.1016/j.biomaterials.2013.02.064 ↗
31. Hypoxia and flow perfusion modulate proliferation and gene expression of articular chondrocytes on porous scaffolds10.1002/aic.13958 ↗
32. Effects of TGF-beta3 and preculture period of osteogenic cells on the chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in a bilayered hydrogel composite10.1016/j.actbio.2010.02.046 ↗
33. Design of a high-throughput flow perfusion bioreactor system for tissue engineering10.1089/ten.tec.2012.0037 ↗
34. Osteogenic differentiation of mesenchymal stem cells on demineralized and devitalized biodegradable polymer and extracellular matrix hybrid constructs10.1002/jbm.a.34610 ↗
35. In vitro generated extracellular matrix and fluid shear stress synergistically enhance 3D osteoblastic differentiation10.1073/pnas.0505661103 ↗
36. Determination of hydroxyproline10.1016/0009-8981(67)90167-2 ↗
37. Cross-linking electrospun type II collagen tissue engineering scaffolds with carbodiimide in ethanol10.1089/ten.2006.0292 ↗
38. Embroidered and surface modified polycaprolactone-co-lactide scaffolds as bone substitute: in vitro characterization10.1007/s10439-009-9731-0 ↗
39. In vitro localization of bone growth factors in constructs of biodegradable scaffolds seeded with marrow stromal cells and cultured in a flow perfusion bioreactor10.1089/ten.2006.12.177 ↗
40. Modulation of osteogenic properties of biodegradable polymer/extracellular matrix scaffolds generated with a flow perfusion bioreactor10.1016/j.actbio.2010.01.011 ↗
41. Protein and mineral composition of osteogenic extracellular matrix constructs generated with a flow perfusion bioreactor10.1021/bm200975a ↗
42. Scott Baggett L, Mikos AG, Kasper FK. Osteogenic differentiation of mesenchymal stem cells on pregenerated extracellular matrix scaffolds in the absence of osteogenic cell culture supplements10.1089/ten.tea.2009.0583 ↗
43. Cryopreservation and in vitro expansion of chondroprogenitor cells isolated from the superficial zone of articular cartilage10.1021/bp049821o ↗
44. Effects of filtration seeding on cell density, spatial distribution, and proliferation in nonwoven fibrous matrices10.1021/bp0100878 ↗
45. Flow perfusion improves seeding of tissue engineering scaffolds with different architectures10.1007/s10439-006-9244-z ↗
46. Scaffolds – flow perfusion bioreactor design
47. Technical note: design of a flow perfusion bioreactor system for bone tissue-engineering applications10.1089/107632703322066723 ↗
48. Solute diffusion within hydrogels. mechanisms and models10.1021/ma980765f ↗
49. The basic science of continuous passive motion in promoting knee health: a systematic review of studies in a rabbit model10.1016/j.arthro.2013.05.028 ↗
50. Animal evidence for hyaluronic acid efficacy in knee trauma injuries. Review of animal-model studies10.1016/j.ptsp.2013.02.001 ↗
51. Immunogenicity of bovine and leporine articular chondrocytes and meniscus cells10.1089/ten.tea.2011.0226 ↗
52. Osteochondral repair in the rabbit model utilizing bilayered, degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds10.1002/jbm.a.30379 ↗
53. Variations in the ratios of co-cultured mesenchymal stem cells and chondrocytes regulate the expression of cartilaginous and osseous phenotype in alginate constructs10.1016/j.bone.2008.07.240 ↗
54. Recent advances in TGF-β effects on chondrocyte metabolism: potential therapeutic roles of TGF-β in cartilage disorders10.1016/S1359-6101(02)00004-7 ↗
55. Systematic assessment of growth factor treatment on biochemical and biomechanical properties of engineered articular cartilage constructs10.1016/j.joca.2008.05.006 ↗
56. Recombinant human bone morphogenetic protein-2 maintains the articular chondrocyte phenotype in long-term culture10.1002/jor.1100140614 ↗
57. Enhanced chondrocyte proliferation and mesenchymal stromal cells chondrogenesis in coculture pellets mediate improved cartilage formation10.1002/jcp.22706 ↗
58. In vivo ectopic chondrogenesis of BMSCs directed by mature chondrocytes10.1016/j.biomaterials.2010.08.052 ↗